| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
254,036,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$22.93 - $22.93 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Fenton Andrew |
Senior V.P., CIO |
• – – |
2012-03-01 |
4 |
S |
$17.00 |
$6,562 |
D/D |
(386) |
96,617 |
|
- |
|
| Hara Izumi |
Sr. VP, Gen. Counsel & Sec. |
• – – |
2012-03-01 |
4 |
S |
$17.00 |
$12,069 |
D/D |
(710) |
200,878 |
|
- |
|
| Fuhrmann Rochelle |
Senior V.P., Finance |
• – – |
2012-03-01 |
4 |
S |
$17.00 |
$12,069 |
D/D |
(710) |
45,339 |
|
- |
|
| Halstead Michael |
Senior V.P., Corp. Development |
• – – |
2012-03-01 |
4 |
S |
$17.00 |
$12,324 |
D/D |
(725) |
41,140 |
|
- |
|
| Van Zoonen Marinus Johannes |
President, Europe/Intl & Mkt. |
• – – |
2012-03-01 |
4 |
S |
$17.00 |
$42,243 |
D/D |
(2,485) |
148,943 |
|
- |
|
| Boissonneault Roger M |
CEO & President |
• • – |
2012-03-01 |
4 |
S |
$17.00 |
$90,436 |
D/D |
(5,320) |
2,253,675 |
|
- |
|
| Van Zoonen Marinus Johannes |
President, Europe/Intl & Mkt. |
• – – |
2012-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,970 |
151,428 |
|
- |
|
| Fenton Andrew |
Senior V.P., CIO |
• – – |
2012-02-21 |
4 |
S |
$16.82 |
$6,880 |
D/D |
(409) |
97,003 |
|
- |
|
| Hara Izumi |
Sr. VP, Gen. Counsel & Sec. |
• – – |
2012-02-21 |
4 |
S |
$16.82 |
$12,651 |
D/D |
(752) |
201,588 |
|
- |
|
| Cross Leland H |
Senior V.P., Tech. Operations |
• – – |
2012-02-21 |
4 |
S |
$16.82 |
$9,925 |
D/D |
(590) |
193,903 |
|
- |
|
| Ellman Herman |
Senior V.P., Clinical Devel. |
• – – |
2012-02-21 |
4 |
S |
$16.82 |
$11,389 |
D/D |
(677) |
194,372 |
|
- |
|
| Van Zoonen Marinus Johannes |
President, Europe/Intl & Mkt. |
• – – |
2012-02-21 |
4 |
S |
$16.82 |
$43,082 |
D/D |
(2,561) |
146,458 |
|
- |
|
| Boissonneault Roger M |
CEO & President |
• • – |
2012-02-21 |
4 |
S |
$16.82 |
$94,677 |
D/D |
(5,628) |
2,258,995 |
|
- |
|
| Herendeen Paul |
Exec. V.P. and CFO |
• – – |
2012-02-21 |
4 |
S |
$16.82 |
$32,518 |
D/D |
(1,933) |
421,963 |
|
- |
|
| Gilligan Claire A |
Senior V.P., Quality |
• – – |
2012-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,790 |
70,643 |
|
- |
|
| Halstead Michael |
Senior V.P., Corp. Development |
• – – |
2012-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,790 |
42,274 |
|
- |
|
| Cross Leland H |
Senior V.P., Tech. Operations |
• – – |
2012-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,790 |
194,493 |
|
- |
|
| Ellman Herman |
Senior V.P., Clinical Devel. |
• – – |
2012-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,790 |
195,049 |
|
- |
|
| Boissonneault Roger M |
CEO & President |
• • – |
2012-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
168,960 |
2,264,623 |
|
- |
|
| Fenton Andrew |
Senior V.P., CIO |
• – – |
2012-01-30 |
4 |
S |
$16.45 |
$5,775 |
D/D |
(351) |
76,622 |
|
- |
|
| Hara Izumi |
Sr. VP, Gen. Counsel & Sec. |
• – – |
2012-01-30 |
4 |
S |
$16.45 |
$10,447 |
D/D |
(635) |
181,550 |
|
- |
|
| Gilligan Claire A |
Senior V.P., Quality |
• – – |
2012-01-30 |
4 |
S |
$16.45 |
$7,897 |
D/D |
(480) |
49,853 |
|
- |
|
| Cross Leland H |
Senior V.P., Tech. Operations |
• – – |
2012-01-30 |
4 |
S |
$16.45 |
$8,292 |
D/D |
(504) |
173,703 |
|
- |
|
| Howard Alvin D |
Sr. V.P., Regulatory Affairs |
• – – |
2012-01-30 |
4 |
S |
$16.45 |
$9,526 |
D/D |
(579) |
217,848 |
|
- |
|
| Fuhrmann Rochelle |
Senior V.P., Finance |
• – – |
2012-01-30 |
4 |
S |
$16.45 |
$4,623 |
D/D |
(281) |
26,011 |
|
- |
|
380 Records found
|
|
Page 6 of 16 |
|
|
